Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Sanofi agreed to invest up to $25 million in the clinical-stage biotechnology company. Adagene said it plans to use the proceeds to fund its research and development activities, including clinical ...

Researchers found that clinically achievable doses of curcumin, the active compound in turmeric, target and suppress ...

A University of Alberta research team has identified a DNA structure that activates the immune system in cancer cells that ...

Sanofi to exercise option on third SAFEbody discovery program and sponsor combination clinical trial with muzastotug ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, discusses how early data from ABBV-706 shows up to 50% ...

The Utah father had been documenting his journey with cancer and the birth of his daughter after being first diagnosed at 25.

A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically ...

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

Curcumin contained in turmeric, the main ingredient of curry, can suppress the early onset of colorectal cancer, according to ...

A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...